Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement
https://doi.org/10.17650/1994-4098-2016-12-1-63-67
Abstract
Systemic drug therapy remains first-line treatment for primarily disseminated breast cancer (BC). The problem in the use of local methods to treat BC patients with distant metastases has not been fully solved. The most of investigations presented in the modern literature suggest that patients show significantly better survivals after adjuvant systemic therapy with local exposure of a primary tumor, the main goal of which is its local monitoring. At the same time, the choice of optimal treatments and their sequence and combination remain to be explored. The paper describes a case of successful organ-sparing chemoradiation therapy for primarily disseminated BC with metachronous bilateral involvement.
About the Authors
Yu. A. Ragulin
A.F. Tsyb Medical Radiology Research Center – Branch of National Medical Radiology Research Center, Ministry of Health of Russia; 4 Koroleva St., Obninsk, Kaluga Region, 249036, Russia
Russian Federation
Russian Federation
G. V. Afonin
A.F. Tsyb Medical Radiology Research Center – Branch of National Medical Radiology Research Center, Ministry of Health of Russia; 4 Koroleva St., Obninsk, Kaluga Region, 249036, Russia
Russian Federation
Russian Federation
G. G. Aminov
A.F. Tsyb Medical Radiology Research Center – Branch of National Medical Radiology Research Center, Ministry of Health of Russia; 4 Koroleva St., Obninsk, Kaluga Region, 249036, Russia
Russian Federation
Russian Federation
A. V. Sidorin
A.F. Tsyb Medical Radiology Research Center – Branch of National Medical Radiology Research Center, Ministry of Health of Russia; 4 Koroleva St., Obninsk, Kaluga Region, 249036, Russia
Russian Federation
Russian Federation
References
1. Состояние онкологической помощи населению России в 2014 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М., 2015. С. 5, 11. [Status of the oncologic assistance to the population in Russia in 2014. Ed. by А.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow, 2015. Pp. 5, 11. (In Russ.)].
2. Chen Y., Thompson W., Semenciw R., Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8(10):855–61.
3. Hartman M., Czene K., Reilly M. et al. Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 2007;25(27):4210–6.
4. Chen S.F., Du C.W., Yang P. et al. The molecular and clinicopathologic characteristics of bilateral breast cancer. Sci Rep 2013;3:2590.
5. Напалков Н.П., Бохман Я.В., Семиглазов В.Ф. Первично-множественные злокачественные опухоли. Л., 1987. 168 с. [Napalkov N.P., Bokhman Ya.V., Semiglazov V.F. Multiple primary neoplasms. Leningrad, 1987. 168 p. (In Russ.)].
6. DeSantis C., Siegel R., Bandi P., Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin 2011;61(6):409–18.
7. Senkus E., Szade J., Pieczyńska B. et al. Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype. Int J Clin Exp Pathol 2013;7(1):353–63.
8. Аблицова Н.В., Ермаков А.В., Рассказова Е.А. и др. Билатеральный синхронный рак молочной железы: отдаленные результаты лечения. Онкология. Журнал им. П.А. Герцена 2014;(1):14–8.
9. [Аblitsovа N.V., Еrmakov А.V., Rasskazovа Е.А. et al. Bilateral synchronous mammary gland cancer: afterhistory. Onkologiya. Zhurnal im. P.A. Gertsena = Оncology. P.А. Herzen Journal 2014;(1):14–8. (In Russ.)].
10. Khan S.A., Stewart A.K., Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002;132(4):620–7.
11. Ruiterkamp J., Ernst M.F., van de Poll-Franse L.V. et al. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol 2009;35(11):1146–51.
12. Fields R.C., Jeffe D.B., Trinkaus K. et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 2007;14(12):3345–51.
13. Blanchard D.K., Shetty P.B., Hilsenbeck S.G., Elledge R.M. Association of surgery with improved survival in stage IV breast cancer patients. Ann Surg 2008;247(5):732–8.
14. Hazard H.W., Gorla S.R., Scholtens D. et al. Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer. Cancer 2008;113(8):2011–9.
15. Сухотько А.С., Зикиряходжаев А.Д., Болотина Л.В. и др. Хирургический этап лечения в комплексной терапии у больных генерализованным раком молочной железы. Онкология. Журнал им. П.А. Герцена 2014;(1):24–9. [Sukhot’ko А.S., Zikiryakhodzhaev А.D., Bolotinа L.V. et al. Surgical stage of treatment in the comprehensive therapy of patients with the generalized mammary gland cancer. Onkologiya. Zhurnal im. P.A. Gertsena = Оncology. P.А. Herzen Journal 2014;(1):24–9. (In Russ.)].
16. Чернова Е.В., Хайленко В.А., Артамонова Е.В. и др. Целесообразность удаления первичной опухоли у больных с впервые выявленным диссеминированным раком молочной железы. Российский онкологический журнал 2013;(2):27–30. [Chernovа Е.V., Khaylenkо V.А., Аrtamonovа Е.V. et al. Expedience of the initial tumor erasion at patients with the new onset disseminated mammary gland cancer. Rossiyskiy onkologicheskiy zhurnal = Russian Oncologic Journal 2013;(2):27–30. (In Russ.)].
17. Le Scodan R., Stevens D., Brain E. et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. J Clin Oncol 2009;27(9):1375–81.
18. Nguyen D.H., Truong P.T., Alexander C. et al. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis? Int J Radiat Oncol Biol Phys 2012;84(1):39–45.
19. Ly B.H., Vlastos G., Rapiti E. et al. Localregional radiotherapy and surgery is associated with a significant survival advantage in metastatic breast cancer patients. Tumori 2010;96(6):947–54.
Review
For citations:
Ragulin Yu.A., Afonin G.V., Aminov G.G., Sidorin A.V. Organ-sparing treatment for primarily disseminated breast cancer with metachronous bilateral involvement. Tumors of female reproductive system. 2016;12(1):63-67. (In Russ.) https://doi.org/10.17650/1994-4098-2016-12-1-63-67
Views:
766
Email this article 